CRISPR Therapeutics AG (CRSP) Financial Ratios Annual - Discounting Cash Flows
CRSP
CRISPR Therapeutics AG
CRSP (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
Price Ratios
Price to Earnings Ratio -12.66 -9.07 -32.28 -4.86 15.24 -28.94 49.55 -8.31 -13.73 -10.7 -15.98 -60.71
Price to Sales Ratio 132.6 94.87 13.36 7,249 6.3 18,596 11.44 438.6 22.89 48.09 1,671 0
Price to Book Ratio 2.67 1.72 2.63 1.69 2.4 6.07 3.53 3.49 5 1.07 -14.19 -58
Price to Free Cash Flow Ratio -15.93 -22.95 -18.21 -5.93 12.59 -39.33 66.26 -13.84 -12.05 -4.26 7.08 -86.13
Price to Operating Cash Flow Ratio -15.93 -23.26 -19.05 -6.38 10.68 -42.36 58.45 -14.24 -13.39 -4.49 6.95 -86.13
Price Earnings to Growth Ratio 3.69 -0.073 0.42 0.018 -0.079 0.055 -0.365 -0.082 1.44 -0.093 -0.057 0
EV to EBITDA -7.67 -3.67 -17.29 -2.45 9.2 -24.53 47.05 -11.53
Liquidity Ratios
Current Ratio 15.64 22.07 17.54 15.3 20.17 18.21 17.29 16.81 17.12 14.56 15.44 0.451
Quick Ratio 15.64 22.07 17.54 15.39 20.17 18.21 17.29 16.81 17.12 14.56 15.44 0.451
Cash Ratio 1.97 3.4 3.58 1.75 7.7 12.4 16.53 16.46 16.52 14.34 15.36 0.44
Debt Ratio 0.101 0.1 0.107 0.109 0.082 0.034 0.049 0 0 0 0.24 0
Debt to Equity Ratio 0.12 0.116 0.127 0.13 0.094 0.037 0.056 0 0 0 -1.32 0
Long Term Debt to Capitalization 0 0 0 0 0 0 0 0 0 0 4.15 0
Total Debt to Capitalization 0.107 0.104 0.112 0.115 0.086 0.036 0.053 0 0 0 4.15 0
Interest Coverage Ratio 0 0 0 0 0 0 0 0 0 -8.46 -238.2 0
Cash Flow to Debt Ratio -1.4 -0.638 -1.09 -2.03 2.4 -3.88 1.08 0 0 0 1.55 0
Margins
Gross Profit Margin -239.7% -215% 64.91% -25,187% 98.03% -49,515% 38.06% -3,542% -70.26% -717.9% -4,990% 0%
Operating Profit Margin -1,283% -1,333% -59.95% -154,395% 40.91% -65,273% 16.14% -5,088% -157.7% -1,319% -10,417% 0%
Pretax Profit Margin -1,032% -1,036% -40.6% -149,197% 41.57% -64,099% 23.24% -5,263% -162.5% -439.9% -10,454% 0%
Net Profit Margin -1,043% -1,046% -41.38% -149,123% 41.36% -64,248% 23.09% -5,281% -166.7% -449.3% -10,457% 0%
Operating Cash Flow Margin -828.7% -407.9% -70.14% -113,702% 59.03% -43,898% 19.57% -3,081% -171% -1,071% 24,060% 0%
Free Cash Flow Margin -832.4% -413.4% -73.37% -122,231% 50.08% -47,279% 17.26% -3,169% -190% -1,129% 23,593% 0%
Return
Return on Assets -17.8% -16.34% -6.89% -28.99% 13.72% -19.08% 6.27% -33.74% -25.19% -6.73% -16.2% -445.3%
Return on Equity -20.08% -18.96% -8.16% -34.67% 15.74% -20.96% 7.12% -42.07% -36.39% -9.96% 88.77% 95.55%
Return on Capital Employed -23.18% -21.66% -10.49% -31.72% 14.19% -20.44% 4.63% -34.46% -25.17% -21.1% -17.24% 1,071%
Return on Invested Capital -26.46% -25.39% -13.1% -35.23% 21.75% -62.87% 70.48% -3,451% -388.5% -934.7% 384.5% 0%
Turnover Ratios
Receivables Turnover Ratio 0 1.4 1.86 0 2,994 3.77 2,925 35.5 15.61 1.64 0.729 0
Payables Turnover Ratio 9.62 7.5 3.41 4.02 1.21 29.62 30.18 22.44 42.59 9.24 7.94 7.17
Inventory Turnover Ratio 0 0 0 -9.84 0 0 0 0 0 0 0 0
Fixed Asset Turnover Ratio 0.137 0.126 1.21 0.001 2.93 0.006 3.98 0.169 2.17 0.246 0.186 0
Asset Turnover Ratio 0.017 0.016 0.166 0 0.332 0 0.271 0.006 0.151 0.015 0.002 0
Per Share Items ()
Revenue Per Share 0.43 0.415 4.69 0.006 12.02 0.008 5.32 0.065 1.03 0.421 0.008 0
Operating Cash Flow Per Share -3.57 -1.69 -3.29 -6.38 7.1 -3.61 1.04 -2.01 -1.75 -4.51 2.03 -0.164
Free Cash Flow Per Share -3.58 -1.71 -3.44 -6.85 6.02 -3.89 0.919 -2.06 -1.95 -4.76 1.99 -0.164
Cash & Short Term Investments 21.59 22.57 21.38 23.35 31.33 25.63 17.35 9.52 6 25.74 5.32 0.032
Earnings Per Share -4.49 -4.34 -1.94 -8.36 4.97 -5.29 1.23 -3.44 -1.71 -1.89 -0.882 0
EBITDA Per Share -5.3 -5.3 -2.56 -8.35 5.15 -5.24 0.946 -3.24 -1.54 -5.48 -0.874 -0.225
Dividend Per Share 0 0 0 0 0 0 0 0 0 0 0 0
Enterprise Value Per Share 40.6 19.44 44.23 20.44 47.42 128.4 44.52 0 0 0 10.08 0
Book Value Per Share 22.35 22.9 23.77 24.12 31.59 25.23 17.27 8.18 4.7 19 -0.993 0
Price Per Share 59.64 39.36 62.6 40.65 75.78 153.1 60.91 28.57 23.48 20.26 14.09 0
Effective Tax Rate -1.04% -0.989% -1.92% 0.05% 0.493% -0.232% 0.666% -0.336% -2.63% -2.13% -0.027% 0.918%
Short Term Coverage Ratio 0 -8.26 -9.3 -31.29 44.33 -20.98 6.68 0 0 0 0 0
Capital Expenditure Coverage Ratio -221.1 -75.1 -21.75 -13.33 6.6 -12.98 8.48 -34.71 -8.97 -18.34 51.5 0
EBIT Per Revenue -12.83 -13.33 -0.6 -1,544 0.409 -652.7 0.161 -50.88 -1.58 -13.19 -104.2 0
EBITDA Per Revenue -12.31 -12.78 -0.546 -1,489 0.429 -635.8 0.178 -49.75 -1.5 -13 -103.7 None
Days of Sales Outstanding 0 260.7 196.7 0 0.122 96.8 0.125 10.28 23.38 223.1 501 0
Days of Inventory Outstanding 0 0 0 -37.08 0 0 0 0 0 0 0 0
Days of Payables Outstanding 37.95 48.7 106.9 90.8 301.2 12.32 12.1 16.26 8.57 39.48 45.98 50.9
Cash Conversion Cycle -37.95 212 89.76 -127.9 -301.1 84.47 -11.97 -5.98 14.81 183.7 455 -50.9
Cash Conversion Ratio 0.795 0.39 1.7 0.762 1.43 0.683 0.848 0.583 1.03 2.38 -2.3 0
Free Cash Flow to Earnings 0.798 0.395 1.77 0.82 1.21 0.736 0.748 0.6 1.14 2.51 -2.26 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us